Northstar Group has closed its fifth Southeast Asia-focused fund with $590 million in commitments. The target was $800 million.
Pioneer Capital, New Zealand Superannuation Fund, and Comprador Holdings have together acquired a 70% stake in Fertility Associates, a New Zealand-based fertility treatment provider.
Indian used car platform Cars24 has raised $400 million in funding – comprising $300 million in equity and $100 million in debt – at a valuation of $3.3 billion.
Indian payments start-up Razorpay has seen its valuation more than double in eight months on closing a $375 million Series F led by Lone Pine Capital, Alkeon Capital Management, and TCV.
Mizuho Bank has led a $200 million Series E round for MoMo, a Vietnam-based mobile wallet provider, at a valuation of more than $2 billion.
Anchor Equity Partners has committed KRW250 billion ($210 million) in pre-IPO funding to Kurly, a Korean grocery delivery platform that earlier this year said it would list locally rather than in the US.
Pacific Equity Partners (PEP) has agreed on exits from two energy infrastructure-related businesses, taking the Australia-based private equity firm to four announced liquidity events within a fortnight.
OfBusiness, an India-based B2B platform focused on industrial supply chain and procurement services, has raised $325 million in Series G funding at a valuation of $5 billion.
Chinese artificial intelligence (AI) technology developer SenseTime has relaunched its IPO on the same terms, albeit excluding US investors, after being placed on another blacklist by the US government.
The Carlyle Group has agreed to sell Sunsho Pharmaceuticals, a Japan-based contract manufacturer of dietary supplements, to Towa Pharmaceutical for JPY47.7 billion ($419.5 million).
KKR has agreed to buy Yayoi, a Japan-based software developer that serves small and medium-sized enterprises (SMEs) from Orix Corporation.
Advantage Partners has raised $150 million for a special purpose acquisition company (SPAC) that will target de-carbonization and renewable energy-related assets with a focus on Asia ex-China and Europe.
Pristyn Care, a clinic operator specializing in minimally evasive surgeries, has joined India’s unicorn boom with a $96 million Series E round featuring Sequoia Capital at a valuation of $1.4 billion.
Australia’s Blackbird Ventures has led a $25 million Series B round for Inventia Life Science, a local start-up that provides 3D cell cultures for research and clinical purposes.
General Catalyst has led a $70 million Series A round for Uni, an Indian buy now, pay later (BNPL) start-up that launched its flagship product just six months ago.
ADV Partners has acquired a significant minority interest in CFL Technologies, a flooring materials business with a presence in multiple locations in the US, China, and Vietnam.
Tiger Global Management has led a $325 million Series E round for Australia-based e-commerce marketing technology provider Rokt.
Walmart and Flipkart, its Indian e-commerce platform, have doubled down on local fresh produce delivery company Ninjacart with a 145 million investment.
Advent International has acquired a majority stake in Guangsheng Medicinal Capsule (GS Capsule), the largest medical capsule maker in China, for an undisclosed sum.
Fuse, which claims to be Indonesia’s largest insurance technology start-up, has raised $25 million in a Series B extension. It comes within six months of a $50 million Series B featuring East Ventures.
SoftBank Vision Fund 2 has led a $60 million Series C funding round for Juspay Technologies, an India-based financial technology start-up that specializes in digital payments.
A broader range of investors will play in the blockchain space as new applications are normalized, although regulation remains the wildcard. Developing markets will punch above their weight
Japanese VC is growing up fast and looking a little less homogenous in the process. A longstanding growth-stage gap is about to disappear as new actors file in
Healthcare’s high-cost, rapidly digitizing profile will persist regardless of how COVID-19 plays out in the coming years. China appears set for consolidation, including in biotech